Enhanced placental cholesterol efflux by fetal HDL in Smith-Lemli-Opitz syndrome. - Wikidata - awgldk - TriplyDB

Enhanced placental cholesterol efflux by fetal HDL in Smith-Lemli-Opitz syndrome.

Enhanced placental cholesterol efflux by fetal HDL in Smith-Lemli-Opitz syndrome.

http://www.wikidata.org/entity/Q34566372

about

Smith-Lemli-Opitz syndrome and inborn errors of cholesterol synthesis: summary of the 2007 SLO/RSH Foundation scientific conference sponsored by the National Institutes of Health.Fetoplacental vascular endothelial dysfunction as an early phenomenon in the programming of human adult diseases in subjects born from gestational diabetes mellitus or obesity in pregnancy.Characterization of placental cholesterol transport: ABCA1 is a potential target for in utero therapy of Smith-Lemli-Opitz syndrome Treatment of Smith-Lemli-Opitz syndrome and other sterol disorders Smith-Lemli-Opitz syndrome.

P2860

Q33909007-21508723-4D95-463E-975C-64D339216440 Q35579449-B8A8C86C-C328-47B7-AF3C-1F8E527EA054 Q36967955-DFF4BB27-A676-4116-8B17-3F82D6F19765 Q38050099-57501B9D-3679-43B7-8E60-93FFB7A16FC0 Q41828275-3351A5BA-C779-4705-8E1D-A29539EF5991

P2860

Enhanced placental cholesterol efflux by fetal HDL in Smith-Lemli-Opitz syndrome.

http://www.wikidata.org/entity/Q34566372

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Enhanced placental cholesterol efflux by fetal HDL in Smith-Lemli-Opitz syndrome.

@ast

Enhanced placental cholesterol efflux by fetal HDL in Smith-Lemli-Opitz syndrome.

@en

Enhanced placental cholesterol efflux by fetal HDL in Smith-Lemli-Opitz syndrome.

@nl

type

label

Enhanced placental cholesterol efflux by fetal HDL in Smith-Lemli-Opitz syndrome.

@ast

Enhanced placental cholesterol efflux by fetal HDL in Smith-Lemli-Opitz syndrome.

@en

Enhanced placental cholesterol efflux by fetal HDL in Smith-Lemli-Opitz syndrome.

@nl

prefLabel

Enhanced placental cholesterol efflux by fetal HDL in Smith-Lemli-Opitz syndrome.

@ast

Enhanced placental cholesterol efflux by fetal HDL in Smith-Lemli-Opitz syndrome.

@en

Enhanced placental cholesterol efflux by fetal HDL in Smith-Lemli-Opitz syndrome.

@nl

P1433

Q34566372-C0EA1463-59EC-44EF-897E-808D610F31CB

P1476

Q34566372-9A112E95-340A-45CE-8B78-F98F6D53A6A5

P2093

Q34566372-378202E8-22AA-41A6-B1C8-8CC8CA320328

Q34566372-4355DEB6-320B-4F03-9D61-05155CF6B98E

Q34566372-5FC001CF-E33A-475D-909E-3F1A8881147D

Q34566372-78DAC141-ACB2-4026-8CEA-38BFF02D61CC

Q34566372-B1CD8C8A-0A96-4D85-B477-64531C6F5137

Q34566372-DC1BBCC4-2867-49E8-BF88-CBEDCBDB0850

Q34566372-F186C070-8E2A-4D32-8485-CF6A8A322C8D

P2860

Q34566372-09807048-9742-4E5A-AF2E-DADA6594B02A

Q34566372-0A768D35-B26C-404F-8B60-41A6FAF0E23A

Q34566372-0E60DC3A-384E-4C57-831A-346A7D779C20

Q34566372-15CA0443-E76B-449F-8BF5-525FE4FC82F0

Q34566372-16884E45-1062-41D2-9892-98D92CF371E8

Q34566372-189AAB55-B958-4EA8-8C6D-B559BC1E9117

Q34566372-190F6CFC-4671-4725-A4F5-30889DFA383F

Q34566372-19CF0AA6-A6D8-4A80-9C7E-9C0E43B512DC

Q34566372-1B06D1D5-9950-4E4E-9213-3653E033891D

Q34566372-1D201EF6-EAEC-4C85-BFCC-7BF0E1E09F6D

P304

Q34566372-B17F3774-D624-4CFE-8449-F74F9B7165AC

P31

Q34566372-EED13CEA-2815-4649-BC71-268656201A42

P356

Q34566372-23AF24DF-C6A6-4931-8E49-11D44B41C360

P433

Q34566372-B570FE24-0DDB-4B05-B564-18DD54AB307E

P478

Q34566372-27763181-C471-4D5A-98B7-4845FEA2DD77

P577

Q34566372-059B7214-0A7F-429C-8167-C790D5BC45EC

P5875

Q34566372-5B4C05FE-3CE8-4471-ADC9-48AB398D2712

P698

Q34566372-6ADE46F0-5F59-4181-B707-ABFFB700F4B3

P932

Q34566372-6BBA8BED-D80F-41F8-A8D6-2C1BBF6E9B04

P356

J.YMGME.2008.01.015

P1433

Molecular Genetics and Metabolism

P1476

Enhanced placental cholesterol efflux by fetal HDL in Smith-Lemli-Opitz syndrome.

@en

P2093

Katie T Jenkins

http://www.w3.org/2001/XMLSchema#string

Laura A Woollett

http://www.w3.org/2001/XMLSchema#string

Leslie Myatt

http://www.w3.org/2001/XMLSchema#string

Louise S Merkens

http://www.w3.org/2001/XMLSchema#string

Matthew R Tubb

http://www.w3.org/2001/XMLSchema#string

Robert D Steiner

http://www.w3.org/2001/XMLSchema#string

W Sean Davidson

http://www.w3.org/2001/XMLSchema#string

P2860

The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway

Apolipoprotein specificity for lipid efflux by the human ABCAI transporter

ABCG1 redistributes cell cholesterol to domains removable by high density lipoprotein but not by lipid-depleted apolipoproteins

Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome.

Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene

The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity

Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome

Markedly inhibited 7-dehydrocholesterol-delta 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes

Fetal demise with Smith-Lemli-Opitz syndrome confirmed by tissue sterol analysis and the absence of measurable 7-dehydrocholesterol Delta(7)-reductase activity in chorionic villi

Endogenous bile acids are ligands for the nuclear receptor FXR/BAR

P304

240-247

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YMGME.2008.01.015

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5505389

http://www.w3.org/2001/XMLSchema#string

P698

18346920

http://www.w3.org/2001/XMLSchema#string

P932

3037116

http://www.w3.org/2001/XMLSchema#string